Tilray Inc. ($TLRY) Stock Forecast: Down 8.1% Today

What is Tilray Inc.?

A leading cannabis company, Tilray (TLRY), observed a significant bearish movement in the market today.

Why is Tilray Inc. going down?

TLRY stock is down 8.1% on Dec 17, 2025 20:41

• Despite positive developments regarding the potential reclassification of marijuana from Schedule I to Schedule III, Tilray faced a bearish movement.
• The surge in Tilray's stock price post speculations on marijuana reclassification by Trump might have prompted profit-taking actions among investors, leading to the bearish movement.
• Uncertainty surrounding the final reclassification decision and profit-taking activities likely contributed to Tilray's stock price decline today.
• The market sentiment towards Tilray remains optimistic, anticipating future ease in federal restrictions and potential improvements in profitability.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?

Shares of publicly traded cannabis companies, including Tilray Brands, Trulieve Cannabis, and Cresco Labs, are experiencing significant gains following reports that the Trump administration is considering reclassifying marijuana from a Schedule I to a Schedule III drug. While President Trump has indicated he is "considering" the reclassification to facilitate research, no official decision has been made. This potential change, which would lessen restrictions but not alter federal legality, has already led to impressive stock jumps for several major cannabis brands.

https://www.fastcompany.com/91461972/pot-stocks-price-rise-tilray-trulieve-cannabis-cresco-schedule-3-news

Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification

Tilray Brands saw a significant 27.5% surge on December 16, 2025, following signals from former President Donald Trump regarding a possible reclassification of marijuana. This news led to a sector-wide cannabis rally, with other companies like Canopy Growth and Cronos Group also experiencing gains. The potential reclassification from a Schedule I to a Schedule III drug could expand the addressable market for cannabis producers like Tilray, allowing for medical use under federal law.

https://finance.yahoo.com/news/stock-market-today-dec-16-222038850.html

Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here?

Tilray (TLRY) shares recently surged 30% due to President Trump's consideration of reclassifying cannabis as a Schedule III drug and authorizing a Medicare pilot program for cannabis products. This policy shift is expected to ease federal restrictions, improve Tilray's profitability, and attract new customers and institutional investments. Options data for March 20, 2026, implies a 50% move in TLRY, with Wall Street analysts maintaining a "Moderate Buy" rating and price targets indicating over 75% upside.

https://finance.yahoo.com/news/option-traders-pricing-nearly-22-201431483.html

Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors' Radars Today

This article highlights five stocks — Tilray Brands, Pfizer, Netflix, Lennar Corp., and Tesla — that garnered significant investor attention due to recent news and market performance. Tilray saw a jump on cannabis reclassification speculation, while Pfizer slipped due to a cautious long-term outlook. Netflix gained traction with a podcast partnership, Lennar Corp. delivered mixed earnings, and Tesla surged to a new high on enthusiasm for its autonomous and robotics prospects.

https://www.benzinga.com/news/25/12/49438929/tilray-brands-pfizer-netflix-lennar-corp-and-tesla-why-these-5-stocks-are-on-investors-radars-today

Trump Weighs Marijuana Changes: 'A Lot Of People Want To See It'

President Donald Trump is considering an executive order to reclassify marijuana as a Schedule III substance, a move that could significantly alter the cannabis market, lessen legal penalties, and facilitate scientific research. While White House officials note no final decision has been made, cannabis stocks saw initial rallies followed by profit-taking. This potential reclassification would alleviate tax burdens and improve access to capital for the cannabis sector.

https://www.benzinga.com/news/politics/25/12/49410096/trump-weighs-marijuana-changes-a-lot-of-people-want-to-see-it

Trending Today

Uniswap ($UNI) Crypto Forecast: Up 5.4% Today

Darden Restaurants Inc. ($DRI) Stock Forecast: Down 0.0% Today

Lam Research Corporation ($LRCX) Stock Forecast: Up 5.4% Today

NASDAQ-100 ($NDX) Index Forecast: Up 1.4% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Up 5.3% Today

Starbucks Corporation ($SBUX) Stock Forecast: Up 5.1% Today

Accenture plc Class A (Ireland) ($ACN) Stock Forecast: Down 1.8% Today

Sunrun Inc. ($RUN) Stock Forecast: Up 6.0% Today

Amdocs Limited ($DOX) Stock Forecast: Up 1.0% Today

Williams-Sonoma Inc. (DE) ($WSM) Stock Forecast: Up 5.4% Today

Tilray Inc. Price History

28.10.2025 - TLRY Stock was down 5.9%

• Tilray's stock took a hit today following the announcement of a 1-for-10 reverse stock split, which often signals a company's struggle to maintain its stock price.
• Despite posting strong Q1 cannabis growth and market share increases, the news of the reverse stock split overshadowed the positive performance, leading to a bearish trend.
• The market's reaction to the reverse stock split indicates investor concerns about Tilray's future prospects and financial health, contributing to the downward pressure on the stock price.
• Overall, the combination of the reverse stock split news and the market's response to it likely fueled the bearish movement in Tilray's stock today.

19.10.2025 - TLRY Stock was down 5.8%

• Despite posting a sharp profitability turnaround in Q1 and showcasing a strong global growth strategy, TLRY experienced a strong bearish movement.
• The market may have reacted negatively due to profit-taking after a significant run-up in the stock price following the positive Q1 results.
• Investors might be concerned about the sustainability of TLRY's profitability and growth strategy, leading to a sell-off in the stock.
• It's possible that the market was expecting even more impressive results or guidance, causing disappointment and triggering the bearish movement.

09.11.2025 - TLRY Stock was up 7.0%

• The launch of Tilray's Ultimate 2025 Holiday Drink Gift Guide featuring festive beverages may have sparked investor interest, hinting at potential expansion in the company's product range and consumer appeal.
• Following recent declines linked to internal changes, the stock saw a successful recovery, hitting a new 1-year peak, potentially influenced by heightened investor trust in Tilray's strategies and market position.
• Today's positive market outlook for Tilray could also be attributed to the overall industry optimism in the cannabis sector, with investors eyeing growth prospects in a sector shaped by changing consumer tastes and regulations.

24.10.2025 - TLRY Stock was up 6.7%

• The introduction of Good Supply vape products in Québec by Tilray Brands could have sparked investor optimism and interest in the company's expansion into new markets, leading to increased buying activity and driving the stock price higher.
• The positive Q1 results and profitability momentum showcased by Tilray Brands indicate strong financial performance, which likely instilled confidence in investors and contributed to the bullish movement of the stock.
• The publication of a new investor presentation highlighting Tilray's leadership in various industries and its global growth strategy may have attracted new investors and bolstered existing shareholders' belief in the company's future prospects, potentially fueling the upward momentum in the stock price.

03.11.2025 - TLRY Stock was down 10.1%

• Tilray's stock has experienced a 24% drop over the past five sessions due to corporate restructuring and a reverse stock split.
• Negative company developments, including the reverse stock split and market pressures, have influenced the downward movement in TLRY's stock.
• Despite positive Q1 cannabis growth and a strengthened domestic position, the adverse effects of corporate changes have outweighed the positive news, leading to ongoing downward pressure on the stock.
• Investor response to Tilray's uncertainties and obstacles has caused the stock to decline further in line with broader market conditions.

16.11.2025 - TLRY Stock was up 5.8%

• TLRY experienced a substantial surge of 44.1% following potential discussions of a reclassification of marijuana at a federal level. This positive news not only impacted TLRY but also other cannabis stocks like Canopy Growth and Aurora Cannabis.
• The company's recent execution of a 10-for-1 reverse stock split, aimed at reducing its float and ensuring compliance with Nasdaq regulations, also influenced the bullish movement by boosting investor confidence.
• Surpassing its 200-day moving average and holding a Zacks Rank #3 (Hold) indicate a potential long-term bullish trend for TLRY, supported by positive earnings estimate revisions and strategic expansion into new markets.
• While the future looks promising, caution is advised due to the volatility in the cannabis sector. It is advisable for investors to closely monitor the situation until official confirmation and details regarding the potential policy change are disclosed.

18.10.2025 - TLRY Stock was down 5.5%

• The bearish movement in TLRY stock today could be attributed to profit-taking by investors after a recent bullish run.
• Despite positive news about Tilray's global growth strategy and advocacy for responsible regulations, market sentiment may have been influenced by broader economic factors or sector rotation.
• Investors might be cautious due to the overall market volatility or specific concerns about the cannabis industry's regulatory environment.
• It's possible that some traders are reacting to technical indicators or short-term market fluctuations rather than the long-term potential of Tilray Brands.

17.11.2025 - TLRY Stock was down 8.1%

• Despite positive developments regarding the potential reclassification of marijuana from Schedule I to Schedule III, Tilray faced a bearish movement.
• The surge in Tilray's stock price post speculations on marijuana reclassification by Trump might have prompted profit-taking actions among investors, leading to the bearish movement.
• Uncertainty surrounding the final reclassification decision and profit-taking activities likely contributed to Tilray's stock price decline today.
• The market sentiment towards Tilray remains optimistic, anticipating future ease in federal restrictions and potential improvements in profitability.

17.11.2025 - TLRY Stock was up 16.2%

• TLRY stock surged by 44.1% due to speculation about a possible reclassification of marijuana as a Schedule III substance through an executive order.
• The surge in TLRY's stock price was driven by optimism about relaxed federal restrictions on cannabis and the potential business opportunities it could bring for companies in the industry.
• Despite the initial rally, the stock price cooled off as White House officials indicated that no final decision had been reached, showcasing the uncertainty surrounding the potential reclassification of marijuana. This led to profit-taking and a moderation in TLRY's price movement.
• Tilray's CEO emphasized the importance of clear regulation in the cannabis industry, especially regarding THC-infused drinks. He highlighted how regulatory clarity could benefit legitimate companies by ensuring quality standards and reducing illicit market activity.

12.11.2025 - TLRY Stock was up 31.7%

• The introduction of Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada has sparked enthusiasm and market interest, contributing to Tilray's upward movement.
• Positive developments related to the legalization of home marijuana cultivation in Florida and potential changes in federal cannabis regulations have bolstered investor confidence in Tilray's future outlook.
• Despite facing challenges such as increased expenses and a stock price decline, Tilray's expansion strategies and focus on evolving into a diversified consumer packaged goods (CPG) company have resonated well with traders and investors, driving the bullish market performance observed today.
• The company's adept handling of regulatory shifts and its ability to seize opportunities within the cannabis sector are expected to be key factors influencing its stock performance in the immediate future.

15.11.2025 - TLRY Stock was down 5.2%

• The bearish movement in TLRY today could be attributed to profit-taking by investors after a series of strong bullish movements.
• Despite the recent surge in TLRY's stock price, the lack of a definitive catalyst or news today may have led to a natural correction in the market.
• The mixed views from analysts regarding TLRY's future performance, balancing policy tailwinds with execution challenges, could have also contributed to the bearish movement as investors reassess the stock's potential.

10.11.2025 - TLRY Stock was up 12.0%

• Despite recent difficulties, Tilray (TLRY) witnessed a notable upward movement in the market today.
• This positive shift could be linked to the company's recent initiatives to expand into areas beyond its core cannabis business, such as broadening its beverage and hemp-derived THC product offerings.
• Investors seem hopeful about Tilray's potential for profitability despite ongoing losses, particularly with its focus on non-cannabis sectors to enhance profit margins.
• Today's optimistic market trend may also be driven by speculation regarding potential policy changes concerning the reclassification of cannabis, which could potentially benefit Tilray's future performance.